Affiliation:
1. Laboratory of Antimicrobial Resistance, Institute of Environmental and Agricultural Biology (X-BIO), Tyumen State University, 625003 Tyumen, Russia
Abstract
Antibiotic resistance is a significant and pressing issue in the medical field, as numerous strains of infectious bacteria have become resistant to commonly prescribed antibiotics. Staphylococcus aureus is a bacterium that poses a grave threat, as it is responsible for a large number of nosocomial infections and has high mortality rates worldwide. Gausemycin A is a new lipoglycopeptide antibiotic that has considerable efficacy against multidrug-resistant S. aureus strains. Although the cellular targets of gausemycin A have been previously identified, detailing the molecular processes of action is still needed. We performed gene expression analysis to identify molecular mechanisms that may be involved in bacterial resistance to gausemycin A. In the present study, we observed that gausemycin A-resistant S. aureus in the late-exponential phase showed an increased expression of genes involved in cell wall turnover (sceD), membrane charge (dltA), phospholipid metabolism (pgsA), the two-component stress-response system (vraS), and the Clp proteolytic system (clpX). The increased expression of these genes implies that changes in the cell wall and cell membrane are essential for the bacterial resistance to gausemycin A. In the stationary phase, we observed a decrease in the expression of genes involved in the phospholipid metabolism (mprF) and Clp proteolytic system (clpX).
Funder
Russian Science Foundation
Subject
Virology,Microbiology (medical),Microbiology
Reference48 articles.
1. The antimicrobial resistance crisis: Causes, consequences, and management;Michael;Front. Public Health,2014
2. Lade, H., and Kim, J.-S. (2021). Bacterial Targets of Antibiotics in Methicillin-Resistant Staphylococcus aureus. Antibiotics, 10.
3. Mechanisms of resistance to daptomycin in Staphylococcus aureus;Casanova;Rev. Esp. Quimioter.,2017
4. Gausemycins A, B: Cyclic lipoglycopeptides from Streptomyces sp.;Tyurin;Angew. Chem. Int. Ed.,2021
5. A Novel Peptide Antibiotic Produced by Streptomyces roseoflavus Strain INA-Ac-5812 with Directed Activity against Gram-Positive Bacteria;Vasilchenko;Front. Microbiol.,2020